HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Yves Blay Selected Research

Pigmented Villonodular Synovitis

1/2018Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial.
8/2015CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.
3/2012Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Yves Blay Research Topics

Disease

176Neoplasms (Cancer)
06/2022 - 06/2002
145Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2003
54Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2022 - 08/2004
30Disease Progression
01/2022 - 01/2006
25Neoplasm Metastasis (Metastasis)
01/2022 - 02/2007
20Neutropenia
01/2022 - 05/2006
20Leiomyosarcoma
11/2020 - 08/2006
19Breast Neoplasms (Breast Cancer)
01/2022 - 06/2004
18Hypertension (High Blood Pressure)
01/2022 - 07/2009
17Osteosarcoma (Osteogenic Sarcoma)
06/2022 - 07/2005
17Fatigue
01/2022 - 09/2006
12Liposarcoma
01/2022 - 01/2004
12Nausea
01/2022 - 09/2006
11Synovial Sarcoma (Synovioma)
07/2019 - 01/2004
10Hemangiosarcoma (Angiosarcoma)
01/2022 - 11/2008
9Thrombocytopenia (Thrombopenia)
01/2022 - 02/2008
9Lymphopenia (Lymphocytopenia)
12/2021 - 12/2004
7Brain Neoplasms (Brain Tumor)
01/2022 - 09/2005
7Aggressive Fibromatosis (Desmoid)
01/2021 - 10/2008
7Ewing Sarcoma (Sarcoma, Ewing)
01/2020 - 10/2008
7Febrile Neutropenia
11/2016 - 12/2004
6Giant Cell Tumors (Giant Cell Tumor)
03/2021 - 09/2012
6Colorectal Neoplasms (Colorectal Cancer)
06/2020 - 07/2007
6Melanoma (Melanoma, Malignant)
01/2020 - 08/2010
6Lymphoma (Lymphomas)
01/2017 - 06/2004
5Infections
01/2022 - 05/2006
5COVID-19
01/2022 - 01/2021
4Carcinoma (Carcinomatosis)
01/2022 - 06/2004
4Hyperthermia
10/2021 - 06/2010
4Giant Cell Tumor of Bone
01/2021 - 08/2012
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2020 - 12/2005
4Weight Loss (Weight Reduction)
01/2020 - 05/2012
4Myxoid Liposarcoma
03/2019 - 07/2007
4Exanthema (Rash)
06/2014 - 09/2006
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2011
3Chondrosarcoma
11/2021 - 01/2017
3Anemia
11/2021 - 04/2003
3Pain (Aches)
01/2021 - 01/2017
3Chordoma
01/2021 - 11/2016

Drug/Important Bio-Agent (IBA)

65Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 06/2002
29Tyrosine Kinase InhibitorsIBA
12/2021 - 03/2007
28TrabectedinIBA
01/2022 - 11/2005
27Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 11/2005
19Biomarkers (Surrogate Marker)IBA
06/2022 - 06/2004
19IfosfamideFDA LinkGeneric
12/2021 - 11/2005
18Sunitinib (Sutent)FDA Link
01/2022 - 03/2007
15Pharmaceutical PreparationsIBA
01/2022 - 06/2004
13Biological ProductsIBA
01/2022 - 11/2005
13Phosphotransferases (Kinase)IBA
12/2021 - 03/2007
13regorafenibIBA
11/2021 - 01/2013
11pazopanibFDA Link
12/2020 - 07/2009
10DenosumabFDA Link
03/2021 - 08/2012
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 06/2004
9CytokinesIBA
01/2022 - 12/2005
9Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2007
9AnthracyclinesIBA
12/2021 - 07/2012
8Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2021 - 08/2004
8VemurafenibIBA
01/2020 - 08/2015
8Cytotoxins (Cytolysins)IBA
06/2017 - 06/2004
7DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2007
7Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 03/2006
7Etoposide (VP 16)FDA LinkGeneric
01/2020 - 03/2006
7Alanine Transaminase (SGPT)IBA
01/2020 - 10/2008
7Dacarbazine (DIC)FDA LinkGeneric
01/2020 - 10/2009
6RNA (Ribonucleic Acid)IBA
01/2022 - 07/2019
6CrizotinibIBA
12/2021 - 01/2015
6Sorafenib (BAY 43-9006)FDA Link
11/2021 - 01/2012
6LigandsIBA
01/2021 - 05/2011
6Docetaxel (Taxotere)FDA Link
01/2020 - 08/2006
6Interleukin-10 (Interleukin 10)IBA
03/2013 - 06/2004
6Interleukin-6 (Interleukin 6)IBA
08/2011 - 06/2004
5nilotinibFDA Link
12/2021 - 09/2009
5ripretinibIBA
12/2021 - 01/2020
5AntibodiesIBA
12/2021 - 07/2007
5Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
5GemcitabineFDA Link
01/2020 - 08/2006
5Messenger RNA (mRNA)IBA
01/2020 - 08/2011
5Monoclonal AntibodiesIBA
12/2017 - 11/2009
5MicroRNAs (MicroRNA)IBA
06/2015 - 01/2011
4cabozantinibIBA
06/2022 - 01/2020
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022 - 03/2015
4Transaminases (Aminotransferases)IBA
01/2020 - 06/2009
4Cisplatin (Platino)FDA LinkGeneric
01/2020 - 11/2008
4eribulinFDA Link
01/2019 - 10/2011
4Bevacizumab (Avastin)FDA Link
10/2018 - 07/2007
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2010 - 08/2004
3ParaffinIBA
01/2022 - 05/2011
3VaccinesIBA
01/2022 - 01/2021
3Anaplastic Lymphoma KinaseIBA
12/2021 - 01/2018

Therapy/Procedure

90Therapeutics
06/2022 - 02/2005
73Drug Therapy (Chemotherapy)
01/2022 - 01/2003
25Radiotherapy
01/2022 - 07/2005
13Adjuvant Chemotherapy
01/2022 - 03/2006
10Immunotherapy
01/2022 - 03/2013
9Neoadjuvant Therapy
01/2022 - 03/2006
8Precision Medicine
01/2022 - 06/2013
4Combination Drug Therapy (Combination Chemotherapy)
01/2019 - 10/2011
4Intravenous Infusions
08/2016 - 01/2012
3Drug Tapering
01/2022 - 05/2006
3Duration of Therapy
11/2021 - 01/2009